Massachusetts General Hospital Cancer Center and Harvard Medical School, Laboratory of Molecular Oncology, Charlestown, MA 02129, USA.
Dev Dyn. 2012 Nov;241(11):1695-707. doi: 10.1002/dvdy.23857. Epub 2012 Sep 17.
Microarray studies have shown that the E2F transcription factor influences the expression of many genes but it is unclear how many of these targets are important for E2F-mediated control of cell proliferation.
We assembled a collection of mutant alleles of 44 dE2F1-dependent genes and tested whether these could modify visible phenotypes caused by the tissue-specific depletion of dE2F1. More than half of the mutant alleles dominantly enhanced de2f1-dsRNA phenotypes suggesting that the in vivo functions of dE2F1 can be limited by the reduction in the level of expression of many different targets. Unexpectedly, several mutant alleles suppressed de2f1-dsRNA phenotypes. One of the strongest of these suppressors was Orc5. Depletion of ORC5 increased proliferation in cells with reduced dE2F1 and specifically elevated the expression of dE2F1-regulated genes. Importantly, these effects were independent of dE2F1 protein levels, suggesting that reducing the level of ORC5 did not interfere with the general targeting of dE2F1.
We propose that the interaction between ORC5 and dE2F1 may reflect a feedback mechanism between replication initiation proteins and dE2F1 that ensures that proliferating cells maintain a robust level of replication proteins for the next cell cycle.
微阵列研究表明,E2F 转录因子影响许多基因的表达,但尚不清楚这些靶标中有多少对于 E2F 介导的细胞增殖控制是重要的。
我们组装了 44 个依赖于 dE2F1 的突变基因的集合,并测试了这些基因是否可以修饰由组织特异性耗尽 dE2F1 引起的可见表型。超过一半的突变等位基因显性增强了 de2f1-dsRNA 表型,这表明 dE2F1 的体内功能可能受到许多不同靶标表达水平降低的限制。出乎意料的是,几个突变等位基因抑制了 de2f1-dsRNA 表型。其中一个最强的抑制子是 Orc5。ORC5 的缺失增加了 dE2F1 减少的细胞的增殖,并特异性地提高了 dE2F1 调节基因的表达。重要的是,这些效应不依赖于 dE2F1 蛋白水平,这表明降低 ORC5 的水平不会干扰 dE2F1 的一般靶向。
我们提出,Orc5 和 dE2F1 之间的相互作用可能反映了复制起始蛋白和 dE2F1 之间的反馈机制,该机制确保增殖细胞在下一个细胞周期中维持复制蛋白的稳健水平。